Catalyst Wire Dossier Catalyst Wire Dossier

FMX103

· Vyne Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FMX103, covering 2020-12-29 to 2020-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea [Phase 3]

See pricing